Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/29/2025

Ultrasound Diagnosis and Management of Fatty Liver Disease

Primary Cause and Diagnostic Considerations

  • A mildly coarsened echo texture of the liver on ultrasound most commonly indicates early hepatic steatosis, which affects 20-30% of the general population and is strongly associated with metabolic syndrome, according to the American College of Radiology 1
  • Hepatic steatosis is the earliest manifestation of non-alcoholic fatty liver disease (NAFLD), which is strongly associated with metabolic syndrome, as reported by the American Association for the Study of Liver Diseases 3
  • The coarsened pattern results from fibrous septa and regenerative changes that create a heterogeneous echotexture, particularly in the background of metabolic liver disease, as noted in Gastroenterology 4

Differential Diagnosis and Diagnostic Accuracy

  • Early fibrosis and cirrhosis both demonstrate coarsened echotexture due to fibrous septa and architectural distortion, making it difficult to differentiate between steatosis and fibrosis using ultrasound alone, as stated by the American College of Radiology 1
  • Ultrasound has high sensitivity (84.8%) and specificity (93.6%) for moderate to severe hepatic fat deposition, but sensitivity drops to 53-65% for mild steatosis, according to the American Institute of Ultrasound in Medicine 2

Risk Stratification and Management

  • All patients with coarsened liver echogenicity require risk stratification using non-invasive fibrosis scores, such as the NAFLD Fibrosis Score or Fibrosis-4 Index (FIB-4), to determine if advanced fibrosis is present, as recommended by the American Association for the Study of Liver Diseases 2
  • For intermediate or high-risk patients, perform elastography-based assessment (transient elastography or ARFI) to evaluate liver stiffness, with cut-offs >12 kPa having >90% specificity for diagnosing compensated advanced chronic liver disease, as reported in the Journal of Hepatology 5
  • Target weight loss of 5-10% of total body weight to improve liver fat and inflammation, combined with aerobic exercise and alcohol restriction, as recommended by the American Heart Association 3